Targeting the immune landscape at presentation and relapse of Immune-Related Lobular Breast Cancer
Targeting the immune landscape at presentation and relapse of Immune-Related Lobular Breast Cancer
批准号:
409960
负责人:
Egan Sean E
金额:
$69.66万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2019
资助国家:
加拿大
项目状态:
已结题
起止时间:
2019-09-01 至 2024-09-01
中文摘要
最近,免疫系统对肿瘤监视的逃避被认为是癌症发展为致命疾病的关键中介。这就为建立疾病模型以开发有效的治疗方法带来了挑战
英文摘要
Recently, escape from tumor surveillance by the immune system has been identified as a critical mediator for cancer progression to lethal disease. This creates a challenge with respect to modeling disease for the development of effective therapy, since m
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
16q hemizygous loss in breast cancer: The central driver for tumor initiation, invasion and progression
-
批准号:452128
-
项目类别:Operating Grants
-
资助金额:$71.33万
-
财政年份:2021
-
负责人:Egan Sean E
-
依托单位:
Notch as master regulator of breast cancer subtype and intratumoral heterogeneity
-
批准号:364267
-
项目类别:Operating Grants
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:Egan Sean E
-
依托单位:
Chromosome 16q, a Cancer Suppressor Chromosome Arm
-
批准号:344719
-
项目类别:Operating Grants
-
资助金额:$54.02万
-
财政年份:2016
-
负责人:Egan Sean E
-
依托单位:
Defining the function of Gata3 and TRPS1, A GATA-like protein, in BC
-
批准号:305494
-
项目类别:Operating Grants
-
资助金额:$54.12万
-
财政年份:2014
-
负责人:Egan Sean E
-
依托单位:
Addressing tumor heterogeneity through identification of subgroup-specific "shared maintenance genes" - the right target for each cancer
-
批准号:222470
-
项目类别:Operating Grants
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:Egan Sean E
-
依托单位:
海外基金